Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Apex Affinity Selects Elsevier’s Gold Standard Drug Database

May 20, 2013

TAMPA, Florida, May 20, 2013 /PRNewswire/ –

Elsevier will provide Apex with essential drug information in a streamlined

database solution

Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, medical
and technical information products and services, today announced an agreement with Apex
Affinity [http://www.apexaffinity.com ], provider of innovative prescription discount
programs for uninsured and underinsured families nationwide. Apex has selected Elsevier’s
Gold Standard Drug Database
[http://www.goldstandard.com/product/gold-standard-drug-database ] for providing current
and accurate drug content to enhance its member products, including a new consumer drug
reference portal.

Apex leverages the purchasing power of millions of consumers to negotiate deep
discounts on brand-name and generic prescriptions at nearly all major big box stores, drug
store chains and independent neighborhood pharmacies. Apex will use Elsevier’s Gold
Standard Drug Database to enable members to compare drug pricing, look-up accurate dosage
information, and learn about alternative therapies and what a medication is used for and
what it does.

“With the Gold Standard Drug Database, we can provide our members with the most
up-to-date drug information in an easy to use format,” said Scott Paul, Apex’s Chief
Executive Officer. “It will help our members make informed decisions about their
medications and their health.”

The Gold Standard Drug Database content is updated daily and has a peer-reviewed
editorial process in place to ensure the highest accuracy of drug product information,
drug pricing and patient education information. Apex will benefit from the database’s
modern technical architecture and flexible implementation, which distinguishes Gold
Standard Drug Database from other drug databases.

“With the implementation of our Gold Standard Drug Database, Apex will have the
confidence that their value-added consumer reference products contain superior drug
information that allows their members to swiftly and effortlessly research their
medications,” said Trygve Anderson, R.Ph.

Vice President of Product Management, Elsevier’s Gold Standard.

For more information about Elsevier’s Gold Standard, please visit

http://www.goldstandard.com.

# # #

About Apex Affinity

Apex Affinity provides innovative services that help organizations reach new
customers, increase satisfaction and loyalty, and create new revenue streams. From
traditional retail discount cards to the latest e-marketing technologies, Apex enables
affinity groups to engage their members, offer high-value services, and grow. For more
information, visit http://www.apexaffinity.com
[http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.apexaffinity.com&esheet=50543519&lan=en-US&anchor=www.apexaffinity.com&index=5&md5=e7039a26ee0f541eac47a54078a152dc ]
.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Reaxys [http://www.elsevier.com/reaxys ], ClinicalKey
[https://www.clinicalkey.com ] and Mosby’s Suite [http://www.confidenceconnected.com ],
which enhance the productivity of science and health professionals, and the SciVal suite
[http://www.scival.com ] and MEDai’s Pinpoint Review [http://www.medai.com ], which help
research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc
[http://www.reedelsevier.com/Pages/Home.aspx ], a world leading provider of professional
information solutions. The group employs more than 30,000 people, including more than
15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies,
Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam
and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam:
REN; New York: RUK and ENL.

        Media contact
        Christopher Capot
        Director, Corporate Relations, Elsevier
        +1-212-633-3164
        c.capot@elsevier.com

SOURCE Elsevier


Source: PR Newswire